IFNAR2 relevance in the clinical outcome of individuals with severe COVID-19.
Fricke-Galindo I, Martínez-Morales A, Chávez-Galán L, Ocaña-Guzmán R, Buendía-Roldán I, Pérez-Rubio G, Hernández-Zenteno RJ, Verónica-Aguilar A, Alarcón-Dionet A, Aguilar-Duran H, Gutiérrez-Pérez IA, Zaragoza-García O, Alanis-Ponce J, Camarena A, Bautista-Becerril B, Nava-Quiroz KJ, Mejía M, Guzmán-Guzmán IP, Falfán-Valencia R.
Fricke-Galindo I, et al. Among authors: zaragoza garcia o.
Front Immunol. 2022 Jul 29;13:949413. doi: 10.3389/fimmu.2022.949413. eCollection 2022.
Front Immunol. 2022.
PMID: 35967349
Free PMC article.